FAM
Formidable Asset Management’s Ginkgo Bioworks DNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-42,288
| Closed | -$14.1K | – | 377 |
|
2024
Q2 | $14.1K | Sell |
42,288
-2,000
| -5% | -$669 | ﹤0.01% | 390 |
|
2024
Q1 | $51.4K | Buy |
44,288
+813
| +2% | +$943 | 0.01% | 383 |
|
2023
Q4 | $73.5K | Buy |
43,475
+19,491
| +81% | +$32.9K | 0.02% | 277 |
|
2023
Q3 | $43.4K | Buy |
23,984
+2,200
| +10% | +$3.98K | 0.01% | 280 |
|
2023
Q2 | $41K | Buy |
21,784
+1,150
| +6% | +$2.16K | 0.01% | 280 |
|
2023
Q1 | $27K | Buy |
20,634
+275
| +1% | +$360 | 0.01% | 301 |
|
2022
Q4 | $34K | Hold |
20,359
| – | – | 0.01% | 306 |
|
2022
Q3 | $56K | Buy |
20,359
+27
| +0.1% | +$74 | 0.01% | 288 |
|
2022
Q2 | $64K | Buy |
20,332
+4,946
| +32% | +$15.6K | 0.01% | 295 |
|
2022
Q1 | $62K | Buy |
+15,386
| New | +$62K | 0.01% | 330 |
|
2021
Q4 | – | Sell |
-60,288
| Closed | -$699K | – | 327 |
|
2021
Q3 | $699K | Buy |
+60,288
| New | +$699K | 0.13% | 151 |
|